Second Sight Medical Products Inc (EYES)

[SwingLong]

Easy $20 today

[jchords]

Looking good again

[mik1234]

green day eyes $

[SwingLong]

Well 10k.... hmmmm...
Either a major dump today below $10 or it rises to some level of stability... we shall see...

[mik1234]

price target????????

[MrPamps]

hmmm 0 posts today. lol let me number one haha

[livendi]

cheers to that,god bless all

[Skidoonut]

It more then likely has nothing to do with "shorts".... this stock has around 30-40 million shares available period. That means it goes both ways very easily if you haven't got the stomach buy the warrants then you can lower your exposure and convert once merger is complete or better yet double down on warrants for the merger but be warned only 7.5 million available on eyesw meaning that will move quick too. Either way just sit back and wait this is solid gold soon.

ALL IN MY OPINION NOT INVESTING ADVICE!

Skidoo

[SwingLong]

Can shorts really hold this down like they have been? I never seen a stock do very low and then very high day after day. Odd...

[jchords]

Recovering nicely past few sessions

[SwingLong]

Dumb...

[Canna_Business]

$EYES $YCBD $RUN $GRNQ $XXII

[billy spec]

25.00 open monday, this now has a patent for prothesis for blind people, all blind people need this 300 million partial blind, 49 mil arw 100% blind, buy all you can more eye proth coming, and more eye rxx, and prothesis for other organs.

[DayTraderOG]

Great looking stock did well last week

[jakec21]

$EYES I only have eyes on you !

[ClayTrader]

* * $EYES Video Chart 03-12-2021 * *

Link to Video - click here to watch the technical chart video

[all right all right]

MNPR low shares

[all right all right]

MNPR low float to the moon moves on small volume

[jchords]

Where is that target coming from?

[webprods]

Alert. Target price $ 52.60

[bcapps66]

Going nuts!

[bcapps66]

There's your $14!

[jchords]

Might get to the 16 to 17 range next

[jchords]

Broke through resistance

[jhdf51]

Why $50?

JHD

[SwingLong]

Can someone help me understand how shorts can bring this down. I know the interest is killing them and they are slowly getting out to minimize loss. So this will drive up soon. I also know weak longs/day traders drive this down too. But yesterday it dip to 9.70 and up to 12.65.

What’s the deal???

Confused here....

[bcapps66]

$50 would be nice ;)

[webprods]

I’m not sure about $14. But for sure $ 50 or more knocking to the door .

[bcapps66]

JMHO...I think so...the pull back today seemed to fill the gap created on Tuesday morning. The other possibility is it trades a little sideways until revs start rolling in from this recent approval.

[SwingLong]

Anyone think we’ll see $14 soon enough?

[jakec21]

I did not sell because I know it will bounce quickly.

[jchords]

Bounce

[SwingLong]

Hmmm....

[Big Barnie]

Sold my position at $15 simply because it was ridiculously priced at this
time IMHO

There was about 100k short position as of two weeks ago. While I would think it is much higher now, why was EYES a target? Low mkt cap, low amount of shares outstanding, potential technology? Who knows

Most, if not all of the fast money traders appear to be gone.

Where is the bottom? Here?

We s/b hearing from Mgmt. about the merger and private placement funding
as soon as this month.

Are there any investors in EYES?

Look forward to serious thoughts

[bcapps66]

I think we filled the gap... should see a rebound off these levels

[SwingLong]

Well looks like I am going to bail with a 50% profit. If this hits $10 I’m out. Got to look out for myself... I hope it stays above $10 and goes to $12 at least.

[ClayTrader]

* * $EYES Video Chart 03-10-2021 * *

Link to Video - click here to watch the technical chart video

[conix]

Metformin may help in reducing the risk for Macular Degeneration


In a large case-control study using a national database of patients, metformin use was associated with reduced odds of developing age-related macular degeneration (AMD). This association was dose dependent, with the greatest benefit at low to moderate doses. When looking only at patients with diabetes, the authors note preservation of the dose-dependent decrease in the odds of patients developing AMD. Metformin does not appear to be protective in patients with diabetes and coexisting diabetic retinopathy. This study suggests that metformin may be useful as a preventive therapy for AMD and provides the basis for potential prospective clinical trials.


In the US, AMD is the leading cause of irreversible blindness in adults older than 50 years. As the older adult population increases worldwide, there is a growing economic burden of AMD. Currently, there are no efficacious preventive measures for AMD development or available treatments for the nonexudative form, which accounts for 90% of cases.

Metformin, the most commonly prescribed oral antihyperglycemic drug for diabetes, has been shown to have antiaging and protective effects against many age-associated diseases. In epidemiology studies, metformin lowers the risk of developing cardiovascular disease, stroke, cancer, dementia, and primary open-angle glaucoma. Metformin also reduces inflammatory markers and increases life span in murine models. These exciting findings have led to the Targeting Aging With Metformin (TAME) trial, a prospective randomized clinical trial to assess metformin’s antiaging effects.

Given the known antiaging effects of metformin and its relatively safe adverse-effect profile, the authors of this study sought to determine if the use of metformin is associated with reduced odds of developing AMD in a large, nationwide sample. They also investigated a potential dose-dependent association in the study population, as well as in a subgroup of only patients with diabetes. Additionally, the authors evaluated whether the findings were dependent on the presence or absence of coexisting diabetic retinopathy (DR).

The authors of the study, published in JAMA Ophthalmology, are Dr. Andrea L. Blitzer and Dr. Dimitra Skondra of the Department of Ophthalmology and Visual Science, University of Chicago Medical Center; Ms. Sandra A. Ham of Center for Health and the Social Sciences, The University of Chicago; and Dr. Kathryn A. Colby of Department of Ophthalmology, New York University, New York.

Since you’re here...we have a small favor to ask. Retina Global is a nonprofit, and we have to depend on your support to sustain the work we do. Hence the need to ask for your help. Retina Global's work is important, since it not only provides help to disadvantaged people, but also provides resources for developing new treatments that can potentially cure blindness. What we do takes a lot of time, money and hard work. But we do it because we believe we have to help stop someone somewhere from going blind. So make a difference. Click here to donate. Your support is much appreciated. Thank you!

The authors found that not only does metformin reduce the odds of developing AMD, but that this outcome is strongest at low to moderate doses and is only seen in the absence of coexisting DR. This study highlights metformin as a possible therapeutic intervention to prevent or slow the progression of AMD. The authors add that future studies will be important to further validate and confirm this finding, in addition to determining the molecular mechanisms involved and which pathogenic pathways of AMD are affected by metformin. If a protective effect of metformin is confirmed in clinical trials, they believe this may lead to a novel therapeutic strategy for this disease, which is the leading cause of blindness in older adults and has no previously established preventive measures.

[SwingLong]

We have lift off!!!

[AFvet86]

I don't know about them but it sounds like a good thing for the share price.

[Ace 420]

Short sale restrictions

[bcapps66]

What's that?

[SwingLong]

SSR day tomorrow???

[SwingLong]

Soon to be over for shorts lmao...
OS 23.21 mil.

Longs win in this. Soon we’ll see the pop...

[jchords]

Still looking for bottom

[SwingLong]

Well, let’s hope we see it stabilized at $11.50 and go up from there...

[bcapps66]

Just drifting lower :(

[SwingLong]

Here comes the bounce!!!

[bcapps66]

Look out belooooooowwww....

[jchords]

Premarket brought it up yesterday. Closed at 11.77 the day before. So technically still up from there. We’ll see what happens